<SEC-DOCUMENT>0001437749-24-012129-index.html : 20240416
<SEC-HEADER>0001437749-24-012129.hdr.sgml : 20240416
<ACCEPTANCE-DATETIME>20240415215227
ACCESSION NUMBER:		0001437749-24-012129
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		6
CONFORMED PERIOD OF REPORT:	20240529
FILED AS OF DATE:		20240416
DATE AS OF CHANGE:		20240415

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Vistagen Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001411685
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				205093315
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37761
		FILM NUMBER:		24846027

	BUSINESS ADDRESS:	
		STREET 1:		343 ALLERTON AVENUE
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080
		BUSINESS PHONE:		650-577-3600

	MAIL ADDRESS:	
		STREET 1:		343 ALLERTON AVENUE
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	VistaGen Therapeutics, Inc.
		DATE OF NAME CHANGE:	20110610

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Excaliber Enterprises, Ltd.
		DATE OF NAME CHANGE:	20070906
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>vtgn20240412_def14a.htm
<DESCRIPTION>FORM DEF 14A
<TEXT>
Document 1 - file: vtgn20240412_def14a.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>a01.jpg
<TEXT>
Document 2 - file: a01.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>capvsnl.jpg
<TEXT>
Document 3 - file: capvsnl.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>capvstsr.jpg
<TEXT>
Document 4 - file: capvstsr.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>proxy_page1.jpg
<TEXT>
Document 5 - file: proxy_page1.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>proxy_page2.jpg
<TEXT>
Document 6 - file: proxy_page2.jpg

</DOCUMENT>
</SEC-DOCUMENT>